The effects of intraovarian platelet rich plasma injection on infertile women with poor ovarian response

The effects of intraovarian platelet rich plasma injection on infertile women with poor ovarian response in Yas Hospital and evaluation of ovarian response to next IVF cycle

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20091012002576N19

Enrollment

Registered

2020-08-21

Start date

2020-07-22

Completion date

Unknown

Last updated

2020-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Female infertility due to poor ovarian response, egg donation candidate. female infertility of other origin

Interventions

Intervention group: platelet reach plasma is prepared from patient's peripheral blood and injected in the ovarian tissue by transvaginal ultrasonographic guidance under anesthesia..

Eligibility

Sex/Gender

Female

Age

20 Years to 45 Years

Inclusion criteria

Inclusion criteria: Age 25-40 years old Abnormal ovarian reserve test Antral follicle count<5 At least one previous IVF cycle <oocyte was retrieved

Exclusion criteria

Exclusion criteria: Ovarian insufficiency due to gonadal dysgenesia and abnormality of chromosoms Male infertility

Design outcomes

Primary

Measure	Time frame
Clinical pregnancy. Timepoint: After fetal transfer. Method of measurement: Ultrasound.	—

Secondary

Measure	Time frame
Chemical pregnancy. Timepoint: Two weeks after fetal transfer. Method of measurement: Laboratory positive beta HCG test.;Gestational sac by transvaginal sonography. Timepoint: Three weeks after embryo transfer. Method of measurement: Transvaginal sonography.;Fetal heart activity by transvaginal sonography. Timepoint: Four weeks after embryo transfer. Method of measurement: Ultrasound.;FSH,LH,AMH,Esteradiol. Timepoint: Before and 3 months after intervention. Method of measurement: Laboratory tests.	—

Measure

Time frame

Chemical pregnancy. Timepoint: Two weeks after fetal transfer. Method of measurement: Laboratory positive beta HCG test.;Gestational sac by transvaginal sonography. Timepoint: Three weeks after embryo transfer. Method of measurement: Transvaginal sonography.;Fetal heart activity by transvaginal sonography. Timepoint: Four weeks after embryo transfer. Method of measurement: Ultrasound.;FSH,LH,AMH,Esteradiol. Timepoint: Before and 3 months after intervention. Method of measurement: Laboratory tests.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Davari-Tanha

Tehran University of Medical Sciences

fatedavtanha@gmail.com+98 21 8880 0115

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026